Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Best Supplements for Improved Atopic Dermatitis Symptoms

Ranked by research evidence. Compare 8 supplements across 14 papers from the biomedical literature, with effect direction, evidence strength, and dose range for each.

Top picks by evidence

  • Low evidence4 studies

    Across 4 studies, all reported beneficial effects of Lactobacillus acidophilus L-92 on atopic dermatitis symptoms, with 2 of 4 studies reaching statistical significance. The predominant effect size is large, driven by two randomized controlled trials (RCTs) in Japanese adults and children. Doses were not consistently reported across studies, but the evidence is strongest for clinical populations with atopic dermatitis.

  • Very low evidence3 studies

    Across 3 review studies, all reported beneficial but predominantly small effects of Lactobacillus brevis SBC8803 on improving atopic dermatitis symptoms, though none provided statistically significant findings. The evidence is based solely on narrative or systematic reviews without original trial data, and no specific dose or population was consistently studied.

8 supplements
  • LowLactobacillus acidophilus L-92Across 4 studies, all reported beneficial effects of Lactobacillus acidophilus L-92 on atopic dermatitis symptoms, with 2 of 4 studies reaching statistical significance. The predominant effect size is large, driven by two randomized controlled trials (RCTs) in Japanese adults and children. Doses were not consistently reported across studies, but the evidence is strongest for clinical populations with atopic dermatitis.4 beneficial4 studies
  • Very lowLactobacillus brevis SBC8803Across 3 review studies, all reported beneficial but predominantly small effects of Lactobacillus brevis SBC8803 on improving atopic dermatitis symptoms, though none provided statistically significant findings. The evidence is based solely on narrative or systematic reviews without original trial data, and no specific dose or population was consistently studied.3 beneficial3 studies
  • Bifidobacterium plantarum2 beneficial2 studies
  • Lactobacillus rhamnosus HA-1141 beneficial1 study
  • Lactobacillus paracasei HA-1961 beneficial1 study
  • Bifidobacterium bifidum Bb-021 beneficial1 study
  • Lactobacillus rhamnosus HA-1111 beneficial1 study
  • Lactobacillus crispatus1 beneficial1 study
Back to top